'Biological drugs' diaporamas de présentation

Biological treatment - principles, technology, examples

1.08k views • 100 slides

Chapter 7 Freeze Drying of Pharmaceuticals

Chapter 7 Freeze Drying of Pharmaceuticals. 7.1 Basic issues for pharmaceutical freeze-drying. 7.1.1 New Dosage forms of pharmaceutical drugs According to its development, pharmaceutical dosage form can be divided into the following generations ?

613 views • 26 slides

Global Market Study on Biological Drugs (2020) - Size, Share, Trend, Analysis

The global biological drugs market is anticipated to grow from an estimated US$ 161,056.5 Mn in 2014 to US$ 287,139.7 by 2020, at a CAGR of 10.1% during the forecast period.

382 views • 22 slides

Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research

Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms. They include a wide range of products derived from animals, humans or microorganisms by using biotechnology. Unlike other drugs,

196 views • 16 slides

Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research

Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms.

187 views • 16 slides

Global Biological Drugs Market Size, Share, Trends Analysis to 2020

Biological drugs are typically derived from living cells and are used in the prevention and treatment of various diseases such as cancer, blood disorders, auto-immune diseases and other medical conditions.

297 views • 14 slides

457 views • 10 slides

Biological Drugs Market Research Report and Global Forecast

In Europe, growth in the aging population is boosting the biological drugs market. According to a UN report, 23.2% of the total German population in 2000 was elderly people and the number is expected to reach 33.2% in 2025. Aging leads to certain disorders such as age-related macular degeneration and glaucoma. These age-related disorders require effective biological drugs for treatment.

240 views • 8 slides

Biosimilars Market - Global Industry Analysis and Forecast t

Biosimilars or follow-on biologics are biopharmaceutical drugs that are similar to approved biological drugs. Biosimilars are different from other generic drugs in terms of raw material and their manufacturing process. Generic drugs are composed of small molecules. However, biosimilars are composed of more complex molecules, such as human insulin and monoclonal antibodies. Many biosimilars are derived from plants, animals, bacteria, viruses and yeast. It is produced by recombinant DNA technology and controlled gene expression methods. Biosimilar drugs are used in prevention and treatment of various severe diseases such as cancer, diabetes, autoimmune diseases, heart attacks, rheumatoid arthritis, oncology, growth hormone deficiency, chronic kidney failure, hematological disease and infectious disease. Biosimilars offer less costly treatment than other biological drugs and synthetic drugs.

265 views • 7 slides

Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research

Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms. They include a wide range of products derived from animals, humans or microorganisms by using biotechnology.

135 views • 6 slides